Who invested in Asieris Pharmaceuticals

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$121Mraised across 2 rounds since 2017, from 2 sources

$15MSeries B$106MSeries D

Latest round: Series D, $106MNov 2020
Step-upi: 7×
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201820192020

$15MSeries B$106MSeries D

First round: Series B, $15M
Biggest round: $106M
Between rounds: 2.8 years

The rounds

Nov 2020
Series D$106M2 new
- Qiming Venture Partners
- CICC
Source recorded
Dec 2017
Series B$15M2 new
- Phoenix
- Zhongguancun
Reported by China Money Network

Founders and team

From Asieris Pharmaceuticals's own website: 4 on the team.

Baohua ChenExecutive Vice President
Helen XuChief Commercial Officer (CCO)
Joanna ZhangChief Medical Officer (CMO)
Richard ZhaoTeam

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2017Series D2020

Qiming Venture PartnersCICC

PhoenixZhongguancun

Everyone who backed them

Qiming Venture PartnersVC firm1round

CICCInvestment bank1round

PhoenixHedge fund1round

Zhongguancunno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Asieris Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.